Anton Gueth, Director at ANTARES PHARMA, INC. (AIS), bought 1,000 shares at $0.60 ($600) on 2009-05-15, disclosed to the SEC on 2009-05-18.
Open-market purchase of $600 AIS by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| ATRS | BUY | 2014-08-13 | $10K | — | Filing → |
| ATRS | SELL | 2013-09-05 | $111K | — | Filing → |
| ATRS | SELL | 2013-08-05 | $110K | — | Filing → |